Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pangramin SLIT HDM-mix in HDM-induced rhinitis
NCT01603056Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Oct 2009
- Primary completion
- Feb 2012
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 3 trial of Pangramin SLIT HDM mix in allergic rhinitis (AR), sponsored by ALK-Abelló. Started Oct 2009; status: completed.
02
Drugs
Pangramin SLIT HDM mix
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01603056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01603056.